Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

NCT00696969 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

634

Enrollment

OTHER

Sponsor class

Conditions

Visceral Leishmaniasis

Interventions

DRUG: Amphotericin B Deoxycholate
DRUG: Ambisome + Miltefosine
DRUG: Ambisome and Paromomycin
DRUG: Miltefosine and Paromomycin

Sponsor

Drugs for Neglected Diseases